- B2B
- Early StageStartup in initial stages
- Website
- Location
- Company size
- 1-10 people
- Total raised
- $250K
- Company type
- Biotech
- Markets
People at Venomyx Therapeutics
Deepankar Roy
Business Development, Technical analysis, Biotech and Pharma, Devices, CRO/CMO, consulting. Biology Research, PhD, PostDoc, Scientist at Genentech and Startups.
William Hayes
Biology Professor at Loma Linda University; studies venomous animals, properties of their venoms, antivenoms, and the treatment of envenomation.
Mads Riegel